Pseudo-four-component synthesis and in silico studies of 5-(5-hydroxy-3-methyl-1H-pyrazol-4-yl)-substituted 5H-chromeno[2,3-b]pyridines

Multicomponent reactions (MCRs) are important processes, in which more than three different reactants directly get converted into one new structure bearing most of the atoms of these reactants. It is a very powerful tool in drug discovery and combinational chemistry. A new pseudo-four-component synthetic approach to 5-(5-hydroxy-3-methyl-1H-pyrazol-4-yl)-substituted 5H-chromeno[2,3-b]pyridines with 68%–95% yields is reported. This MCR opens an efficient and convenient way to substituted 5H-chromeno[2,3-b]pyridines, which are promising compounds in medicinal chemistry and for the treatment of lung cancer through inhibition of aldo-keto reductase 1B10. A new consensus approach of molecular docking and molecular dynamics was applied for the investigation of interaction of synthesized 5H-chromeno[2,3-b]pyridines and aldo-keto reductase 1B10.